Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest Expense - Fed FundsInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalInterest Income - Trading Account AssetsNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cohen (COHN) Research & Development (2024 - 2026)

Cohen filings provide 3 years of Research & Development readings, the most recent being $1.3 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 51.63% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.0 million, a 49.89% increase, with the full-year FY2025 number at $3.6 million, up 55.7% from a year prior.
  • Research & Development hit $1.3 million in Q1 2026 for Cohen, up from $906000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.3 million in Q1 2026 to a low of $456000.0 in Q1 2024.
  • Median Research & Development over the past 3 years was $829000.0 (2025), compared with a mean of $788111.1.
  • The widest YoY moves for Research & Development: up 86.08% in 2025, down 11.17% in 2025.
  • Cohen's Research & Development stood at $815000.0 in 2024, then increased by 11.17% to $906000.0 in 2025, then skyrocketed by 38.74% to $1.3 million in 2026.
  • The last three reported values for Research & Development were $1.3 million (Q1 2026), $906000.0 (Q4 2025), and $869000.0 (Q3 2025) per Business Quant data.